サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1571399

欧州の骨関節浸潤用関節内注射の市場規模と予測、地域シェア、動向、成長機会分析：タイプ別、エンドユーザー別、国別

Europe Intra-Articular Injection for Osteoarticular Infiltrations Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, End User (Hospitals, Orthopedic Clinics, and Others), and Country

出版日
ページ情報
英文 92 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州の骨関節浸潤用関節内注射の市場規模と予測、地域シェア、動向、成長機会分析：タイプ別、エンドユーザー別、国別
出版日: 2024年10月07日
発行: The Insight Partners
ページ情報: 英文 92 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の骨関節浸潤用関節内注射の市場規模は、2023年の9,743万米ドルから2031年には1億5,708万米ドルに成長すると予測され、2023年から2031年のCAGRは6.2%と予測されています。

変形性関節症の関節内注射は、変形性関節症に罹患した関節に薬剤を直接注入する医療処置です。このアプローチは、痛みの軽減と関節機能の改善を目的としています。これらの注射の利点に関する医療従事者や患者の意識の高まりと、医療インフラや技術革新への投資の増加が相まって、これらの治療へのアクセスが増加しています。変形性関節症の有病率の増加と注射技術の進歩は、欧州の骨関節浸潤用関節内注射市場規模の拡大に寄与している注目すべき要因です。しかし、関節内注射に伴う副作用が欧州の骨関節浸潤用関節内注射市場の成長を妨げています。

関節内注射は、骨関節浸潤に対する治療の革新的で新しい分野の一つです。メーカーは、革新的な薬剤の安全性、有効性、信頼性を確保するため、さまざまな臨床試験に取り組んでいます。例えば、2024年5月、スウェーデンのシナートロ社は、変形性関節症候補薬SYN321の臨床試験を実施するため、373万～736万米ドルの増資を開始しました。現在、278万米ドルの米国助成金を獲得するための最終段階にあります。さらに2023年4月には、治験薬候補SYN321の第1/2a相ヒト初臨床試験を開始するための承認をスウェーデン医療製品庁およびスウェーデン倫理審査局から得ています。この地域の他の市場企業も関節内注射の臨床試験を実施しており、革新的な製品の開発につながる可能性があります。例えば、2022年8月、ドイツのグルーネンタール社はレジニフェラトキシン（RTX）の世界臨床第III相プログラムで最初の患者を登録しました。グルネンタール社は、成人におけるRTXの関節内注射の安全性と有効性を調査するため、欧州、米国、ラテンアメリカ、南米、日本の約200か所で3つの臨床試験を実施しました。試験で観察された結果は、主にベースラインから52週までのWOMAC（Western Ontario and McMaster Universities）変形性関節症指数における身体機能と痛みのスコアの改善に焦点を当てたものです。この第III相臨床試験が終了すれば、RTXは欧州、米国、日本で販売承認を取得する予定です。同社は2024年に新薬承認申請を提出する予定であり、RTXの市場参入は2025年になる可能性を示しています。したがって、新興国市場での臨床試験の増加により、同地域における革新的な製品の開発が促進され、それが今後数年間の欧州の骨関節浸潤用関節内注射剤市場の成長に寄与すると期待されます。

タイプ別洞察

タイプ別では、欧州の骨関節浸潤用関節内注入剤市場はタイプ1コラーゲンとヒアルロン酸に区分されます。ヒアルロン酸セグメントは、2023年に欧州の骨関節浸潤用関節内注射市場で最大のシェアを占めました。ヒアルロン酸注射は、他の治療オプションに反応しなかった患者の膝痛を治療するために採用されています。ヒアルロン酸注入療法における最近の進歩は、成長軌道を大きく拡大させています。市場における新規製品の開拓と導入への強力な注力は、このセグメントの成長を支え、それによって市場の成長に貢献すると期待されています。

The Centers for Disease Control and Prevention（米国疾病予防管理センター）、World Health Organization（世界保健機関）、National Center for Biotechnology Information（米国生物工学情報センター）などは、欧州の骨関節浸潤用関節内注射市場レポート作成時に参照した一次情報および二次情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の作成
    • データの三角測量
    • 国レベルのデータ

第4章 欧州の骨関節浸潤用関節内注射市場情勢

  • PEST分析
  • コラーゲン注射がHA注射より優れている理由についての情報
  • 価格分析

第5章 欧州の骨関節浸潤用関節内注射市場：主要市場力学

  • 骨関節浸潤用関節内注射の欧州市場- 主要市場力学
  • 市場促進要因
    • 変形性関節症の有病率の上昇
    • 注射技術の進歩
  • 市場抑制要因
    • 関節内注射に伴う副作用
  • 市場機会
    • 変形性関節症に対する関節内注射の戦略的取り組み
  • 今後の動向
    • 臨床試験数の増加
  • 促進要因と抑制要因の影響

第6章 欧州の骨関節浸潤用関節内注射市場の分析

  • 欧州の骨関節浸潤用関節内注射の市場収益（2021年～2031年）
  • 欧州の骨関節浸潤用関節内注射の市場予測・分析

第7章 欧州の骨関節浸潤用関節内注射市場分析：タイプ別

  • タイプ1コラーゲン
  • ヒアルロン酸

第8章 骨関節浸潤用関節内注射市場の分析：エンドユーザー別

  • 病院
  • 整形外科クリニック
  • その他

第9章 欧州の骨関節浸潤用関節内注射市場の分析：国別

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • その他欧州

第10章 業界情勢

  • 骨関節浸潤用関節内注射市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略
    • 市場概要

第11章 企業プロファイル

  • Bioventus Inc
  • SEIKAGAKU CORPORATION
  • Maxigen Biotech Inc.
  • ?stem Medical Inc.
  • Sanofi SA
  • Ferring Pharmaceuticals
  • Fidia Pharma USA Inc.
  • Biotech Healthcare Group
  • Bioteck S.p.A.
  • I+MED

第12章 付録

図表

List Of Tables

  • Table 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation
  • Table 2. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 7. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 8. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 9. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 10. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 11. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 12. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 13. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 14. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 17. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 18. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 19. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 20. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 21. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 22. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 23. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 24. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 25. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 26. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by Type 1 Collagen
  • Table 27. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 28. Recent Organic Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 29. Recent Inorganic Growth Strategies in the Intra-Articular Injection For Osteoarticular Infiltrations Market
  • Table 30. Glossary of Terms, Europe Intra-Articular Injection For Osteoarticular Infiltrations Market

List Of Figures

  • Figure 1. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Share (%) - by End User, 2023 and 2031
  • Figure 9. Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
目次
Product Code: TIPRE00039338

The Europe intra-articular injection for osteoarticular infiltrations market size is expected to grow from US$ 97.43 million in 2023 to US$ 157.08 million by 2031; it is projected to register a CAGR of 6.2% during 2023-2031.

Intra-articular injections for osteoarthritis are a medical procedure where medication is injected directly into a joint affected by osteoarthritis. This approach is intended to reduce pain and improve joint function. Increasing awareness among healthcare professionals and patients regarding the benefits of these injections, combined with increasing investment in healthcare infrastructure and innovation, is facilitating increased access to these treatments. The increasing prevalence of osteoarthritis and advancements in injection techniques are noteworthy factors contributing to the expansion of the Europe intra-articular injection for osteoarticular infiltrations market size. However, the side effects associated with intra-articular injections hinder the Europe intra-articular injection for osteoarticular infiltrations market growth.

Intra-articular injections are among the innovative and emerging fields of treatment for osteoarticular infiltrations. Manufacturers are involved in various clinical trials to ensure the safety, efficacy, and reliability of innovative drugs. For instance, in May 2024, the Swedish Company, Synartro, initiated a capital raise of between US$ 3.73 and 7.36 million to conduct a clinical study of the osteoarthritis candidate SYN321. It is in the final phase to secure an EU grant of US$ 2.78 million. Additionally, in April 2023, the company received approval from the Swedish Medical Products Agency and the Swedish Ethical Review Authority to start the phase 1/2a first-in-human clinical study of the investigational drug candidate SYN321. Other market players in the regions are also conducting clinical trials for intra-articular injections, which can lead to the development of innovative products. For instance, in August 2022, Grunenthal, a German company enrolled the first patient in its global clinical Phase III program for resiniferatoxin (RTX). Grunenthal has conducted three trials in ~200 locations across Europe, the US, Latin America, South Africa, and Japan to investigate the safety and effectiveness of intra-articular injections of RTX in adults. The outcomes observed in the trials mainly focus on an improvement in the physical function and pain score in the Western Ontario and McMaster Universities (WOMAC) osteoarthritis index from baseline to 52 weeks. Upon completion, the Phase III program is intended to provide marketing approval for RTX in Europe, the US, and Japan. The company intends to submit a new drug application in 2024, indicating the potential market entry of RTX in 2025. Therefore, the increasing number of clinical trials are expected to enhance the development of innovative products in the region, which, in turn, will contribute to the Europe intra-articular injection for osteoarticular infiltrations market growth in coming years.

Type-Based Insights

Based on type, the Europe intra-articular injection for osteoarticular infiltrations market is segmented into Type 1 collagen and hyaluronic acid. The hyaluronic acid segment held the largest Europe intra-articular injection for osteoarticular infiltrations market share in 2023 Hyaluronic acid injections are employed to treat knee pain in patients who were not responsive to other treatment options. Recent advancements in hyaluronic acid injection therapy have significantly expanded growth trajectory. A robust focus on developing and introducing novel products in the market is expected to support the growth of the segment, thereby contributing to market growth.

The Centers for Disease Control and Prevention, World Health Organization, and National Center for Biotechnology Information are among the primary and secondary sources referred to while preparing the Europe intra-articular injection for osteoarticular infiltrations market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Information on why collagen injections are better than HA injections
  • 4.4 Pricing Analysis

5. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics

  • 5.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Osteoarthritis
    • 5.2.2 Advancements in Injection Techniques
  • 5.3 Market Restraints
    • 5.3.1 Side Effects Associated with Intra-Articular Injections
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Intra-Articular Injection for Osteoarticular Infiltrations
  • 5.5 Future Trends
    • 5.5.1 Increasing Number of Clinical Trials
  • 5.6 Impact of Drivers and Restraints:

6. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis

  • 6.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Forecast and Analysis

7. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by Type

  • 7.1 Type 1 Collagen
    • 7.1.1 Overview
    • 7.1.2 Type 1 Collagen: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Hyaluronic Acid
    • 7.2.1 Overview
    • 7.2.2 Hyaluronic Acid: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Analysis - by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Hospitals: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Orthopedic Clinics
    • 8.2.1 Overview
    • 8.2.2 Orthopedic Clinics: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Country Analysis

  • 9.1 Europe
    • 9.1.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Countries
    • 9.1.2 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.1 Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Revenue and Forecast and Analysis - by Country
      • 9.1.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.2.1 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.2.2 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.2.3 Germany: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.3.1 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.3.2 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.3.3 United Kingdom: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.4 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.4.1 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.4.2 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.4.3 France: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.5 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.5.1 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.5.2 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.5.3 Italy: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.6 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.6.1 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.6.2 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.6.3 Spain: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.7 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.7.1 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.7.2 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.7.3 Denmark: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User
      • 9.1.2.8 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.2.8.1 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type
        • 9.1.2.8.2 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by Type 1 Collagen
        • 9.1.2.8.3 Rest of Europe: Europe Intra-Articular Injection For Osteoarticular Infiltrations Market Breakdown by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Intra-Articular Injection For Osteoarticular Infiltrations Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Bioventus Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 SEIKAGAKU CORPORATION
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Maxigen Biotech Inc.
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 ?stem Medical Inc.
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Sanofi SA
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Ferring Pharmaceuticals
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Fidia Pharma USA Inc.
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Biotech Healthcare Group
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 Bioteck S.p.A.
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 I+MED
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms